Larry A. Sklar
49Patents
10h-index
83Co-inventors
78Inventor score
Filing activity: Nov 24, 1997 → Apr 24, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6890487B1 | Flow cytometry for high throughput screening | Emerging Cross-Sectional Technologies | 151 | Expired |
| US5895764A | Controlled sheath flow injection cytometry | Emerging Cross-Sectional Technologies | 66 | Expired |
| US6315952A | Plug flow cytometry for high throughput screening and drug discovery | Emerging Cross-Sectional Technologies | 31 | Expired |
| US7368084B2 | Flow cytometry for high throughput screening | Emerging Cross-Sectional Technologies | 25 | Expired |
| US6878556B2 | Flow cytometry for high throughput screening | Emerging Cross-Sectional Technologies | 23 | Expired |
| US6638481B2 | Plug flow cytometry for high throughput screening and drug discovery | Emerging Cross-Sectional Technologies | 16 | Expired |
| US8021872B2 | Flow cytometry for high throughput screening | Emerging Cross-Sectional Technologies | 14 | Active |
| US7842244B2 | Flow cytometry for high throughput screening | Emerging Cross-Sectional Technologies | 12 | Active |
| US7875721B2 | Compounds for binding to ERα/β and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof | Chemistry; Metallurgy | 10 | Active |
| US8268571B2 | Flow cytometry for high throughput screening | Emerging Cross-Sectional Technologies | 10 | Active |
| US8487100B2 | Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof | Chemistry; Metallurgy | 9 | Active |
| US7416903B2 | Wavy interface mixer | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6498189B1 | Method for induction of L-selectin shedding | Human Necessities | 5 | Expired |
| US9125899B1 | Modulators of GTPases and their use | Emerging Cross-Sectional Technologies | 4 | Active |
| US9642835B2 | Modulators of GTPase and use in relevant treatment | Emerging Cross-Sectional Technologies | 4 | Active |
| US8637261B2 | Flow cytometry for high throughput screening | Emerging Cross-Sectional Technologies | 3 | Active |
| US8835506B2 | Methods and related compositions for the treatment of cancer | Human Necessities | 3 | Active |
| US9034857B2 | Methods for reducing superoxide anions in eukaryotic organisms | Physics | 3 | Active |
| US9572820B2 | Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits | Physics | 2 | Active |
| US6660532B1 | Modular assembly for reagentless affinity separation and detection of analyte | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8765803B1 | Rab7 GTPase inhibitors and related methods of treatment | Human Necessities | 2 | Active |
| US10039771B2 | Method for cancer cell reprogramming | Physics | 1 | Active |
| US7018846B1 | Display of receptors and analysis of binding interactions and drug libraries | Physics | 1 | Expired |
| US10857130B2 | Modulators of GTPases and their use | Emerging Cross-Sectional Technologies | 1 | Active |
| US9012235B2 | Multi-sample particle analyzer and method for high throughput screening | Physics | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.